CD4 and acute respiratory distress syndrome: A monocyte dysregulation with IL-1β production and the expansion of CD4+ CD28 null T cells, a subset of CD4+ lymphocytes with strong cytotoxic activity, are also proven molecular mechanisms involved in CMD-ARDs [4].